Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
50
GNW Quote, Financials, Valuation and Earnings
Last price:
$7.46
Seasonality move
:
5.63%
Day range:
$7.13 - $7.36
52-week range:
$5.99 - $8.08
Dividend yield:
0%
P/E ratio:
14.98x
P/S ratio:
0.45x
P/B ratio:
0.35x
Volume:
5.2M
Avg. volume:
7.3M
1-year change:
14.87%
Market cap:
$3B
Revenue:
$7.1B
EPS (TTM):
$0.49
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Genworth Financial has 29.43% upside to fair value with a price target of $9.50 per share.
GNW vs. S&P 500
-
Over the past 5 trading days, Genworth Financial has underperformed the S&P 500 by -2.59% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Genworth Financial does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Genworth Financial revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Genworth Financial reported revenues of $1.8B.
Earnings Growth
-
Genworth Financial earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Genworth Financial reported earnings per share of $0.13.
Enterprise value:
-2.2B
EV / Invested capital:
--
Price / LTM sales:
0.45x
EV / EBIT:
-3.63x
EV / Revenue:
-0.31x
PEG ratio (5yr expected):
0.09x
EV / Free cash flow:
-9.44x
Price / Operating cash flow:
13.86x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
0.24%
Net Income Margin (TTM):
3.02%
Return On Equity:
2.3%
Return On Invested Capital:
1.97%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $7.3B | $7.4B | $7.1B | $1.8B | $1.8B | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $1.17 | $0.19 | $0.49 | $0.31 | $0.13 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $79.2B | $73.3B | $68.7B | $26B | $25.5B | |
| Total Assets | $98.6B | $93.5B | $91.2B | $89.2B | $87.3B | |
| Current Liabilities | -- | -- | -- | -- | -- | |
| Total Liabilities | $83.8B | $78.3B | $83B | $80.3B | $77.6B | |
| Total Equity | $14.8B | $15.2B | $8.2B | $8.9B | $9.7B | |
| Total Debt | $2.9B | $1.8B | $1.6B | $1.6B | $1.5B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1.2B | $473M | $229M | -$107M | $34M | |
| Cash From Investing | $959M | $1B | $704M | $143M | -$14M | |
| Cash From Financing | -$1.7B | -$1.3B | -$993M | -$299M | -$177M | |
| Free Cash Flow | $1.2B | $473M | $229M | -$107M | $34M | |
GNW
Sector
Market Cap
$3B
$627.9M
Price % of 52-Week High
90.85%
89.42%
Dividend Yield
0%
1.97%
Shareholder Yield
6.24%
4.06%
1-Year Price Total Return
14.87%
7.77%
Beta (5-Year)
1.056
0.585
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$7.48
200-day SMA
Buy
Level
$7.07
Bollinger Bands (100)
Buy
Level
6.6 - 7.42
Chaikin Money Flow
Sell
Level
-14.1M
20-day SMA
Sell
Level
$7.64
Relative Strength Index (RSI14)
Sell
Level
46.66
ADX Line
Sell
Level
33.67
Williams %R
Neutral
Level
-77.8854
50-day SMA
Buy
Level
$7.25
MACD (12, 26)
Buy
Level
2.01
25-day Aroon Oscillator
Buy
Level
48
On Balance Volume
Sell
Level
-18.3M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
Sell
CA Score
(Annual)
Level (-2.2812)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (7)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Sell
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Genworth Financial Inc is a diversified insurance holding company that provides various mortgage and life insurance products. The company has three main operating business segments: Enact, Life and Annuities segment and Long-Term Care Insurance. The company's product portfolio includes various financial products such as traditional life insurance, mortgage insurance, fixed annuities, and variable annuities. Majority of the revenue is generated by the Enact segment. The company earns maximum of its revenue in the United States.
Stock Forecast FAQ
In the current month, GNW has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The GNW average analyst price target in the past 3 months is $9.50.
-
Where Will Genworth Financial Stock Be In 1 Year?
According to analysts, the consensus estimate is that Genworth Financial share price will rise to $9.50 per share over the next 12 months.
-
What Do Analysts Say About Genworth Financial?
Analysts are divided on their view about Genworth Financial share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Genworth Financial is a Sell and believe this share price will drop from its current level to $9.50.
-
What Is Genworth Financial's Price Target?
The price target for Genworth Financial over the next 1-year time period is forecast to be $9.50 according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is GNW A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Genworth Financial is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of GNW?
You can purchase shares of Genworth Financial via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Genworth Financial shares.
-
What Is The Genworth Financial Share Price Today?
Genworth Financial was last trading at $7.46 per share. This represents the most recent stock quote for Genworth Financial. Yesterday, Genworth Financial closed at $7.34 per share.
-
How To Buy Genworth Financial Stock Online?
In order to purchase Genworth Financial stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
